Vorinostat (SAHA) and breast cancer: an overview

A Wawruszak, L Borkiewicz, E Okon, W Kukula-Koch… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer (BC) is the most frequent malignancy diagnosed in 2020
worldwide. Despite significant advances in BC therapy, its pathogenesis is still not fully …

Differential molecular mechanistic behavior of HDACs in cancer progression

T Singh, P Kaur, P Singh, S Singh, A Munshi - Medical Oncology, 2022 - Springer
Genetic aberration including mutation in oncogenes and tumor suppressor genes transforms
normal cells into tumor cells. Epigenetic modifications work concertedly with genetic factors …

[HTML][HTML] Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?

G Natale, E Fini, PF Calabrò, M Carli, M Scarselli… - Cancer Letters, 2023 - Elsevier
Beyond its use as an antiepileptic drug, over time valproate has been increasingly used for
several other therapeutic applications. Among these, the antineoplastic effects of valproate …

HSP70s in breast cancer: promoters of tumorigenesis and potential targets/tools for therapy

AE Kabakov, VL Gabai - Cells, 2021 - mdpi.com
The high frequency of breast cancer worldwide and the high mortality among women with
this malignancy are a serious challenge for modern medicine. A deeper understanding of …

Epigenetic Regulation in Breast Cancer: Insights on Epidrugs

A Kim, K Mo, H Kwon, S Choe, M Park, W Kwak… - Epigenomes, 2023 - mdpi.com
Breast cancer remains a common cause of cancer-related death in women. Therefore,
further studies are necessary for the comprehension of breast cancer and the revolution of …

[HTML][HTML] Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer

SD Pramanik, A Kumar Halder, U Mukherjee… - Frontiers in …, 2022 - frontiersin.org
Histone deacetylases (HDAC) are enzymes that play a role in chromatin remodeling and
epigenetics. They belong to a specific category of enzymes that eliminate the acetyl part of …

Control of redox homeostasis by short-chain fatty acids: implications for the prevention and treatment of breast cancer

C González-Bosch, PA Zunszain, GE Mann - Pathogens, 2023 - mdpi.com
Breast cancer is the leading cause of death among women worldwide, and certain subtypes
are highly aggressive and drug resistant. As oxidative stress is linked to the onset and …

Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner

F Giordano, A Paolì, M Forastiero, S Marsico… - Journal of Translational …, 2023 - Springer
Background Breast cancer is the second leading cause of death among women after lung
cancer. Despite the improvement in prevention and in therapy, breast cancer still remains a …

Assessment of pharmacological interactions between SIRT2 inhibitor AGK2 and paclitaxel in different molecular subtypes of breast cancer cells

A Wawruszak, J Luszczki, A Czerwonka, E Okon… - Cells, 2022 - mdpi.com
Breast carcinoma (BC) is the most commonly diagnosed type of cancer in women in the
world. Although the advances in the treatment of BC patients are significant, numerous side …

Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin

A Granit, K Mishra, D Barasch… - Frontiers in Cell and …, 2022 - frontiersin.org
Cisplatin is an effective chemotherapeutic agent for treating triple negative breast cancer
(TNBC). Nevertheless, cisplatin-resistance might develop during the course of treatment …